Keros Therapeutics is a clinical-stage biopharmaceutical company that develops novel therapeutics targeting the transforming growth factor-beta (TGF-ß) superfamily of proteins.…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Keros →Already a subscriber? Sign in
Xcout Intel tracks Keros continuously — this profile deepens as new filings, funding, people and hiring data arrive.